Daniel Bensen - 02 Nov 2021 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Operating Officer
Signature
/s/ John Healy, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
02 Nov 2021
Net transactions value
$0
Form type
4
Filing time
04 Nov 2021, 19:42:33 UTC
Previous filing
17 Sep 2021
Next filing
08 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +83,626 $0.000000 83,626 02 Nov 2021 Common Stock 83,626 $24.15 Direct F1
transaction TYRA Stock Option (Right to Buy) Award $0 +7,964 $0.000000 7,964 02 Nov 2021 Common Stock 7,964 $24.15 Direct F2
transaction TYRA Stock Option (Right to Buy) Award $0 +7,964 $0.000000 7,964 02 Nov 2021 Common Stock 7,964 $24.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F2 The option vests based on achievement of a performance objective.